Ellington Management Group’s Eli Lilly LLY Stock Holding History

Ellington Management Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,500	Closed	-$483K	–	508
2018 Q3	$483K	Buy	+4,500	New	+$450K	0.13%	210
2018 Q2	–	Sell	-9,700	Closed	-$750K	–	686
2018 Q1	$750K	Buy	9,700 +1,400	+17%	+$113K	0.05%	290
2017 Q4	$701K	Buy	+8,300	New	+$706K	0.11%	144
2017 Q2	–	Sell	-4,400	Closed	-$370K	–	786
2017 Q1	$370K	Buy	+4,400	New	+$352K	0.01%	403
2016 Q4	–	Sell	-10,100	Closed	-$811K	–	692
2016 Q3	$811K	Buy	+10,100	New	+$808K	0.22%	113
2016 Q2	–	Sell	-4,300	Closed	-$310K	–	386
2016 Q1	$310K	Buy	+4,300	New	+$325K	0.13%	230

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ellington Management Group's LLY Position: Q4 2018 in Review

Ellington Management Group sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 4,500 shares — an estimated $483K sold.

Ellington Management Group first reported a position in LLY in Q1 2016 and held it in 6 quarters. The position peaked at $811K in Q3 2016. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

Ellington Management Group reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
Ellington Management Group sold 4,500 Eli Lilly shares in Q4 2018, an estimated $483K.
Ellington Management Group first reported a position in Eli Lilly in Q1 2016 and held it in 6 quarters.
Ellington Management Group's Eli Lilly position peaked at $811K in Q3 2016.
1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Ellington Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.